Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |